Journal article

Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Matthews, D. R. (2011). Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study. Evidence-Based Medicine, 16(2), 45–46.

MLA Style

Matthews, DR. “Fenofibrate and Statin Therapy, Compared with Placebo and Statin, Slows the Development of Retinopathy in Type 2 Diabetes Patients of 10 Years Duration: the ACCORD Study.” Evidence-Based Medicine, vol. 16, no. 2, 2011, pp. 45–46.

Chicago Style

Matthews, DR. 2011. “Fenofibrate and Statin Therapy, Compared with Placebo and Statin, Slows the Development of Retinopathy in Type 2 Diabetes Patients of 10 Years Duration: the ACCORD Study.” Evidence-Based Medicine 16 (2): 45–46.
Print

Access Document

Publisher copy:: 10.1136/ebm1155

Authors

+ Matthews, DR More by this author

Role:: Author

Journal:: Evidence-based medicine More from this journal
Volume:: 16
Issue:: 2
Pages:: 45-46
Publication date:: 2011-04-01
DOI:: 10.1136/ebm1155
EISSN:: 1473-6810
ISSN:: 1356-5524

Language:: English
Pubs id:: pubs:127177
UUID:: uuid:1560c4e8-f72d-4fac-9671-b619b6fccb66
Local pid:: pubs:127177
Source identifiers:: 127177
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_1560c4e8f72d4fac9671b619b6fccb66

Terms of use

Copyright date:: 2011

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP